Regulatory agencies worldwide have requested drug authorization holders to evaluate drug product and drug substances processes for the possibility of introducing nitrosamine impurities with a systematic risk assessment.
Bachem assesses both our solid phase peptide synthesis (SPPS) and liquid phase peptide synthesis (LPPS) processes regarding their potential of introducing nitrosamines.
This webinar will focus on our approach to execute the risk assessment for peptides produced by SPPS. We will explain the general risk factors and present their assessment for Bachem’s SPPS-related raw materials and processes.
Matteo Villain, Ph.D.
Vice President of CMC Development, Bachem Americas, Inc.
Matteo joined Bachem in 2004 as Director of Research. During his career at Bachem Americas he covered both the position of VP of R&D responsible for process development, and VP of Manufacturing responsible for commercial production. In his current position as VP of CMC Development, he supports Bachem customers in identifying the activities assuring a successful CMC development. Matteo holds a Doctorate in Chemistry and Pharmaceutical Technology from University of Milano, School of Pharmacy.
Lael Cheung, Ph.D.
Business Development Manager, Bachem Americas, Inc.
Lael Cheung joined Bachem Americas in December 2019 as a Business Development Manager. He helps clients initiate and sustain GMP projects at various Bachem sites, focusing on peptide-related New Chemical Entities (NCEs). He obtained a BA in chemistry and biology from the University of Pennsylvania, followed by a PhD in organic chemistry from the University of California, Irvine. He is a co-author on several research publications and patents, most of which focus on bioconjugate chemistry and in vivo fluorescence imaging. Before joining Bachem, Lael worked at Bracco Research USA and LI-COR Biosciences, gaining experience in product development and market research.
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.